ARCHIVES

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

This article is from The Cancer Letter archive.

Vol. 27 No. 46 | December 14, 2001

Download PDF Visit The Full Archive

Related Articles

Clinical Education Program Phase Out Opposed By NCAB Committee

February 14, 1986

White House Expected To Nominate Nobel Laureate Harold Varmus As NCI Director

March 17, 2010

NIH reauthorization Bill slates For House Vote;

May 28, 1993

President Accepts Compromise On HEW Money Bill; Cancer Gets $523.6 Million

December 21, 1973

In Brief: New NCAB Members Briefed At Orientation Wogan Resigns From Board; Parry Names NCCP Deputy

September 10, 1982

Docetaxel As Adjuvant Therapy Shows Benefit Over Standard

June 28, 2002